PRONIA

Personalised Prognostic Tools for Early Psychosis Management

 Coordinatore LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Dr.
Nome: Nikolaos
Cognome: Koutsouleris
Email: send email
Telefono: +49 8951605717
Fax: +49 8951603413

 Nazionalità Coordinatore Germany [DE]
 Sito del progetto http://www.pronia.eu
 Totale costo 9˙242˙843 €
 EC contributo 6˙000˙000 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2013-INNOVATION-1
 Funding Scheme CP-FP
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-10-01   -   2018-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Dr.
Nome: Nikolaos
Cognome: Koutsouleris
Email: send email
Telefono: +49 8951605717
Fax: +49 8951603413

DE (MUENCHEN) coordinator 863˙015.00
2    DYNAMIC EVOLUTION GMBH

 Organization address address: LICHTENBERGSTRASSE 8
city: GARCHING
postcode: 85748

contact info
Titolo: Mr.
Nome: Michael
Cognome: Jovicevic
Email: send email
Telefono: +49 89 31 888 501

DE (GARCHING) participant 833˙220.00
3    THE UNIVERSITY OF BIRMINGHAM

 Organization address address: Edgbaston
city: BIRMINGHAM
postcode: B15 2TT

contact info
Titolo: Ms.
Nome: May
Cognome: Chung
Email: send email
Telefono: 441214000000
Fax: 441214000000

UK (BIRMINGHAM) participant 689˙755.00
4    TURUN YLIOPISTO

 Organization address address: YLIOPISTONMAKI
city: TURUN YLIOPISTO
postcode: 20014

contact info
Titolo: Dr.
Nome: Mari
Cognome: Riipinen
Email: send email
Telefono: +358 2 3336054
Fax: +358 2 3336363

FI (TURUN YLIOPISTO) participant 681˙550.00
5    UNIVERSITAET BASEL

 Organization address address: Petersplatz 1
city: BASEL
postcode: 4003

contact info
Titolo: Prof.
Nome: Stefan
Cognome: Borgwardt
Email: send email
Telefono: +41 612655119
Fax: +41 61 265 45 88

CH (BASEL) participant 673˙298.00
6    KLINIKUM DER UNIVERSITAET ZU KOELN

 Organization address address: Kerpener Strasse 62
city: KOELN
postcode: 50937

contact info
Titolo: Mrs.
Nome: Petra
Cognome: Schreiner-Kaub
Email: send email
Telefono: +49 22147898413
Fax: +49 2214781498413

DE (KOELN) participant 650˙340.00
7    UNIVERSITA DEGLI STUDI DI UDINE

 Organization address address: VIA PALLADIO 8
city: UDINE
postcode: 33100

contact info
Nome: Marina
Cognome: Dorligh
Email: send email
Telefono: +39 0432494202

IT (UDINE) participant 641˙953.00
8    GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O

 Organization address address: Oskar-von-Miller-Ring 29
city: MUENCHEN
postcode: 80333

contact info
Titolo: Ms.
Nome: Birgit
Cognome: Fuchs
Email: send email
Telefono: +49 8928810414

DE (MUENCHEN) participant 400˙000.00
9    General Electric Deutschland Holding GmbH

 Organization address address: Martin-Behaim str. 10
city: Neu-Isenburg
postcode: 63263

contact info
Nome: Manuela
Cognome: Abraham
Email: send email
Telefono: +49 89 5528 3208

DE (Neu-Isenburg) participant 293˙279.00
10    GE HEALTHCARE GMBH - GEHC

 Organization address address: BEETHOVENSTRASSE 239
city: SOLINGEN
postcode: 42655

contact info
Titolo: Dr.
Nome: Katrin
Cognome: Herrmann
Email: send email
Telefono: +49 89 96281 152

DE (SOLINGEN) participant 273˙590.00
11    UNIVERSITY OF MELBOURNE

 Organization address address: PARKVILLEOFFICE OF THE VICE CHANCELLOR
city: MELBOURNE
postcode: 3010

contact info
Titolo: Ms.
Nome: Melinda
Cognome: Heron
Email: send email
Telefono: +61 383442052
Fax: +613 9347 6730

AU (MELBOURNE) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

seekers    related    disease    prediction    burden    services    psychoses    psychosis    health    suicide    risk    prognostic    mental    affective    expensive    quantification    brain    tools   

 Obiettivo del progetto (Objective)

'Affective and non-affective psychoses have a major negative impact on human society. They account for 6.3% of the global burden of disease and cost €207 billion per year in Europe alone, making them the most expensive brain-related disorders and even more expensive than cardiovascular diseases. This socioeconomic burden is largely caused by two core disease features: onset in adolescence and early adulthood and long-term disabling disease courses. Both factors lead to enduring social and vocational exclusion and contribute to 8-20 times higher suicide rates in affected patients. Reliable and accessible prognostic tools will alleviate this burden by enabling individualised risk prediction, thus facilitating the targeted prevention of psychoses. Thus, we will first use routine brain imaging and complementary data to optimise our candidate biomarkers for the prediction and staging of psychoses and generate a prognostic system that generalises well across mental health services. Secondly, we will implement new multi-modal risk quantification tools to predict mental health-related disability in young help-seekers. The fusion of these tools with clinical knowledge will produce cybernetic prognostic services that accurately identify help-seekers at the highest risk of psychosis, poor functioning and suicide-related mortality. During this project we will secure our intellectual property rights and transform into a European company to commercially exploit these prognostic services through internet-based telemedicine applications. This will provide psychosis risk profiling tools to diverse target groups in the healthcare markets, including care-givers, the pharmaceutical industry and research institutions. By disseminating objective risk quantification, these products will provide firm diagnostic grounds for preventive therapy, improving outcomes and reducing costs. Thus, they will offer a unique selling proposition to the mental health sectors in Europe and beyond.'

Altri progetti dello stesso programma (FP7-HEALTH)

PEDDOSE.NET (2010)

Dosimetry and Health Effects of Diagnostic Applications of Radiopharmaceuticals with particular emphasis on the use in children and adolescents

Read More  

ISSC (2010)

An integrated surveillance system for infectious disease in rural China: generating evidence for early detection of disease epidemics in resource-poor settings

Read More  

ESPOIR (2012)

European clinical study for the application of regenerative heart valves

Read More